Plans, PBMs Ponder High Cost of Compounded Meds
From Drug Benefit News - While there is plenty of attention being paid to the cost of new hepatitis C drug Sovaldi, another area of drug spend that has unexpectedly hit plan sponsors’ radar screens is the sharp rise in price and utilization of compounded drugs. Read
No comments:
Post a Comment